Not sure where to start? Get matched →
— Lab results

NAD+ Injection, lot 1629756.

NAD+ 200mg/mL in 3.1mL Cartridges. Compounded by Mills Pharmacy & Apothecary, Birmingham, MI. Tested August 17, 2026 by Eagle Analytical Services Inc., Houston, TX. This lot was tested for sterility, bacterial endotoxins, potency.

— Results

SterilityPassScanRDI rapid sterility
Bacterial endotoxins< 2 EU/mLUSP <85> · Spec limit 350 EU/mL
Potency95.0% of label — 190 mg/mL measured vs 200 mg/mL labelUSP <621>
Eagle submission ETX-260805-0452, sample received 8/6/2026. Potency tested 8/13–8/17/2026, sterility 8/6–8/8/2026, endotoxin 8/7–8/8/2026. The report prints no acceptance range for potency. Lab disclaimer on potency: "The potency method(s) used for testing passed system suitability requirements per Eagle SOP 2.500.001. Product-specific method validation is not available for this sample."
Transcribed from the laboratory's certificate of analysis for this lot. Applies to this lot only. This certificate covers the 3 tests above and does not report purity, identity, ph, particulate matter, container closure integrity.

Formulation

Injectable vial10 mL · 100 mg/mL
NAD+1,000 mg
Pepti Pen cartridge3 mL cartridge (300 units) · 250 mg/mL
NAD+750 mg
Amounts shown are per unit. Compounded fresh at a US FDA-registered pharmacy.